Notice2024-02268
National Cancer Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 6, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 25 (Tuesday, February 6, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 25 (Tuesday, February 6, 2024)]
[Notices]
[Pages 8222-8223]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-02268]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications/contract proposals and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications/contract
proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-7: SBIR Contract Review Meeting.
Date: February 15, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W236, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Shuli Xia, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W236, Rockville, Maryland 20850, 240-276-5256,
<a href="/cdn-cgi/l/email-protection#9eedf6ebf2f7b0e6f7ffdef0f7f6b0f9f1e8"><span class="__cf_email__" data-cfemail="4f3c273a23266137262e0f21262761282039">[email protected]</span></a>.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-8: NCI Clinical and Translational Cancer Research.
Date: February 29, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W110, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Priya Srinivasan, Ph.D., Scientific Review
Officer, Resource and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W110, Rockville, Maryland 20850, 240-276-5619,
<a href="/cdn-cgi/l/email-protection#89f9fbe0f0e8a7fafbe0e7e0ffe8fae8e7c9e7e0e1a7eee6ff"><span class="__cf_email__" data-cfemail="09797b607068277a7b6067607f687a686749676061276e667f">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; R13 Conference Grant Review.
Date: March 6, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W552, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Xiaozhong Alex Bao, Ph.D., Scientific Review
Officer, Program Coordination and Referral Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W552, Rockville, Maryland 20850, 240-276-5070,
<a href="/cdn-cgi/l/email-protection#3d7f5c52457d505c545113535455135a524b"><span class="__cf_email__" data-cfemail="692b080611290408000547070001470e061f">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Advancing Cancer Control Equity Research (U19).
Date: March 13-14, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W124, Rockville, Maryland 20850, (Virtual
Meeting).
Contact Person: Eun Ah Cho, Ph.D., Scientific Review Officer,
Resources and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W124, Rockville, Maryland 20850, 240-276-6342,
<a href="/cdn-cgi/l/email-protection#4e2d26212b0e232f27226020272660292138"><span class="__cf_email__" data-cfemail="adcec5c2c8edc0ccc4c183c3c4c583cac2db">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399,
[[Page 8223]]
Cancer Control, National Institutes of Health, HHS)
Dated: January 31, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-02268 Filed 2-5-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 6, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.